Treatment of Parkinson's Disease with Mild Cognitive Impairment (No Dementia)
This protocol targets a specific sub-population: patients with Parkinson's disease who have developed mild cognitive impairment but have not progressed to dementia. This distinction matters clinically — PD-MCI and PD with dementia are defined by separate criteria and require different management strategies.
The clinical situation: Parkinson's disease complicated by mild cognitive impairment, with dementia explicitly absent. Cognitive disorders in PD are classified separately as PD-MCI and PD with dementia according to international definition criteria, making accurate staging essential before selecting a management approach.
Treatment approach — partial overview
The protocol incorporates structured non-pharmacological interventions — both cognitive and physical in nature — as the primary approach in this setting. There is also explicit guidance on which pharmacological agents are not indicated for PD-MCI. The full regimen, including specific parameters and complete pharmacological recommendations, is available in the structured protocol below.
References
DOI: 10.1186/s42466-024-00325-4
- Cognitive disorders in PD patients were divided into PD with mild cognitive impairment (PD-MCI) and PD with dementia (PDD) according to international definition criteria.
- Cognitive training should be offered to individuals with PD-MCI.
- Physical endurance training should be conducted in the aerobic range for 2–3 times a week, lasting 45 to 60 min each session.
- Pharmacological treatment with Rivastigmine, Donepezil, and Galantamine should not be used for PD-MCI.
View source ↗